These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29343527)

  • 1. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA; Bouffet E; Packer RJ; Reginald A
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
    Ullrich NJ; Prabhu SP; Packer RJ; Goldman S; Robison NJ; Allen JC; Viskochil DH; Gutmann DH; Perentesis JP; Korf BR; Fisher MJ; Kieran MW;
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28833. PubMed ID: 33336845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
    Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
    Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA
    Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.
    Arnljots U; Nilsson M; Bolzani R; Benassi M; Sandvik U; Munoz DM; Blomgren K; Hellgren K
    PLoS One; 2024; 19(7):e0305548. PubMed ID: 38990917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
    Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
    Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J; Schüttauf F; Salamon JM; Kordes U; Friedrich RE; Mautner VF
    Anticancer Res; 2019 Feb; 39(2):827-831. PubMed ID: 30711963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma.
    Parrozzani R; Miglionico G; Leonardi F; Pulze S; Trevisson E; Clementi M; Opocher E; Licata V; Viscardi E; Pilotto E; Frizziero L; Midena E
    Acta Ophthalmol; 2018 Dec; 96(8):e1004-e1009. PubMed ID: 30284379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the visual pathway in paediatric optic pathway glioma patients using probabilistic tractography, and correlations with visual acuity.
    Hales PW; Smith V; Dhanoa-Hayre D; O'Hare P; Mankad K; d'Arco F; Cooper J; Kaur R; Phipps K; Bowman R; Hargrave D; Clark C
    Neuroimage Clin; 2018; 17():541-548. PubMed ID: 29527480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.
    Hepokur M; Sarici AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis 1-associated optic pathway gliomas.
    Shofty B; Ben Sira L; Constantini S
    Childs Nerv Syst; 2020 Oct; 36(10):2351-2361. PubMed ID: 32524182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.